These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35793474)

  • 1. A general framework for subgroup detection via one-step value difference estimation.
    Johnson D; Lu W; Davidian M
    Biometrics; 2023 Sep; 79(3):2116-2126. PubMed ID: 35793474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subgroup identification for treatment selection in biomarker adaptive design.
    Lu TP; Chen JJ
    BMC Med Res Methodol; 2015 Dec; 15():105. PubMed ID: 26646831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplicity-adjusted semiparametric benefiting subgroup identification in clinical trials.
    Schnell PM; Müller P; Tang Q; Carlin BP
    Clin Trials; 2018 Feb; 15(1):75-86. PubMed ID: 29035083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying optimal dosage regimes under safety constraints: An application to long term opioid treatment of chronic pain.
    Laber EB; Wu F; Munera C; Lipkovich I; Colucci S; Ripa S
    Stat Med; 2018 Apr; 37(9):1407-1418. PubMed ID: 29468702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAPITAL: Optimal subgroup identification via constrained policy tree search.
    Cai H; Lu W; Marceau West R; Mehrotra DV; Huang L
    Stat Med; 2022 Sep; 41(21):4227-4244. PubMed ID: 35799329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A nonparametric method for value function guided subgroup identification via gradient tree boosting for censored survival data.
    Zhang P; Ma J; Chen X; Shentu Y
    Stat Med; 2020 Dec; 39(28):4133-4146. PubMed ID: 32786155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistical learning of origin-specific statically optimal individualized treatment rules.
    van der Laan MJ; Petersen ML
    Int J Biostat; 2007; 3(1):Article 6. PubMed ID: 19122792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST; Whitley E; Peters TJ; Mulheran PA; Egger M; Davey Smith G
    Health Technol Assess; 2001; 5(33):1-56. PubMed ID: 11701102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian inference for optimal dynamic treatment regimes in practice.
    Rodriguez Duque D; Moodie EEM; Stephens DA
    Int J Biostat; 2023 Nov; 19(2):309-331. PubMed ID: 37192544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ON TESTING CONDITIONAL QUALITATIVE TREATMENT EFFECTS.
    Shi C; Song R; Lu W
    Ann Stat; 2019 Aug; 47(4):2348-2377. PubMed ID: 31190690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating optimal individualized treatment rules with multistate processes.
    Bakoyannis G
    Biometrics; 2023 Dec; 79(4):2830-2842. PubMed ID: 37015010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LIBERTI: A SMART study in plastic surgery.
    Hibbard JC; Friedstat JS; Thomas SM; Edkins RE; Hultman CS; Kosorok MR
    Clin Trials; 2018 Jun; 15(3):286-293. PubMed ID: 29577741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantile-Optimal Treatment Regimes.
    Wang L; Zhou Y; Song R; Sherwood B
    J Am Stat Assoc; 2018; 113(523):1243-1254. PubMed ID: 30416233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation and evaluation of linear individualized treatment rules to guarantee performance.
    Qiu X; Zeng D; Wang Y
    Biometrics; 2018 Jun; 74(2):517-528. PubMed ID: 28960239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A general statistical framework for subgroup identification and comparative treatment scoring.
    Chen S; Tian L; Cai T; Yu M
    Biometrics; 2017 Dec; 73(4):1199-1209. PubMed ID: 28211943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incorporating Patient Preferences into Estimation of Optimal Individualized Treatment Rules.
    Butler EL; Laber EB; Davis SM; Kosorok MR
    Biometrics; 2018 Mar; 74(1):18-26. PubMed ID: 28742260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subgroup analysis with semiparametric models toward precision medicine.
    Yuan A; Chen X; Zhou Y; Tan MT
    Stat Med; 2018 May; 37(11):1830-1845. PubMed ID: 29575056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On optimal treatment regimes selection for mean survival time.
    Geng Y; Zhang HH; Lu W
    Stat Med; 2015 Mar; 34(7):1169-84. PubMed ID: 25515005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of predictive signatures for treatment selection in precision medicine with survival outcomes.
    Chen YC; Lee UJ; Tsai CA; Chen JJ
    Pharm Stat; 2018 Mar; 17(2):105-116. PubMed ID: 29297979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.